software for windows, release 9.1 (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
software for windows, release 9.1
Software For Windows, Release 9.1, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+for+windows%2C+release+9%2E1/version+9+4+for+windows/pm38141866-125-10-21
Average 90 stars, based on 1 article reviews
Software For Windows, Release 9.1, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software+for+windows%2C+release+9%2E1/version+9+4+for+windows/pm38141866-125-10-21
Average 90 stars, based on 1 article reviews
software for windows, release 9.1 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy Article Snippet: Statistical Analysis All statistical analyses were performed using SAS Software for Windows, Article Title: 7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy Article Snippet: Statistical Analysis All statistical analyses were performed using Article Title: Implication of Enterohepatic Re-Circulation on Single Dose Bioequivalence Evaluation of Two Brands of Clonidine Hydrochloride Tablets in Healthy Human Volunteers Article Snippet: Statistical analysis was performed using the SAS® software for windows, Article Title: Toxicology and Pharmacokinetic Studies in Mice and Nonhuman Primates of the Nontoxic, Efficient, Targeted Hexameric FasL: CTLA4-FasL Article Snippet: The Article Title: Repeat-dose and embryo-fetal developmental toxicity of zinpentraxin alfa. Article Snippet: Zinpentraxin alfa is a recombinant human pentraxin-2 (PTX-2) developed for the treatment of various fibrotic diseases with the hypothesis that supplementing endogenous PTX-2 levels through intravenous administration should increase its regulatory capacity in circulation and at the site of disease, thereby promoting healing and reducing fibrosis.. Zinpentraxin alfa has been studied in various clinical trials, particularly in patients with idiopathic pulmonary fibrosis, where it has demonstrated efficacy in slowing decline in lung function in a phase 2 study.. In the present investigation, we summarize findings from 14-day repeat-dose toxicity studies in rats and cynomolgus monkeys supporting early clinical development of zinpentraxin alfa. Article Title: Impact of Repeated Dietary Counseling Between Infancy and 14 Years of Age on Dietary Intakes and Serum Lipids and Lipoproteins Article Snippet: Statistical analyses were performed with the SAS software for Windows, |